View Financial HealthCreotech Instruments 配当と自社株買い配当金 基準チェック /26Creotech Instruments配当を支払う会社であり、現在の利回りは32.45%です。主要情報32.4%配当利回り0%バイバック利回り総株主利回り0%将来の配当利回り0%配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Jun 11Creotech Instruments S.A. has completed a Follow-on Equity Offering in the amount of €481 million.Creotech Instruments S.A. has completed a Follow-on Equity Offering in the amount of €481 million. Security Name: Series M Ordinary Bearer Shares Security Type: Common Stock Securities Offered: 650,000 Price\Range: €740 Transaction Features: Regulation S; Subsequent Direct ListingReported Earnings • Jun 04First quarter 2026 earnings released: zł2.95 loss per share (vs zł0.59 profit in 1Q 2025)First quarter 2026 results: zł2.95 loss per share (down from zł0.59 profit in 1Q 2025). Revenue: zł18.0m (down 30% from 1Q 2025). Net loss: zł8.41m (down zł9.82m from profit in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has increased by 64% per year, which means it is tracking significantly ahead of earnings growth.New Risk • Jun 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding).お知らせ • May 08Creotech Instruments S.A., Annual General Meeting, Jun 03, 2026Creotech Instruments S.A., Annual General Meeting, Jun 03, 2026, at 14:00 Central European Standard Time.お知らせ • Apr 04Creotech Instruments S.A. (WSE:CRI) completed the Spin-Off of Creotech Quantum S.A.Creotech Instruments S.A. (WSE:CRI) agreed to Spin-Off Quantum segments on April 17, 2025. As part of the spinoff, Creotech Instruments shareholders will be allocated shares in the new quantum company in proportion to their holdings. The allocation of shares will take place through a public offering of shares. The quantum company is expected to go public on the WSE, at the same time, a new company will be created to focus on the development and commercialization of quantum systems so far developed at Creotech and assuming the prospectus procedure before Poland's financial market regulator KNF and the receival of all corporate approvals proceeds without delay and the spinoff proposal receives the approval of the shareholders. The estimated date for concluding the spinoff is late 2025/early 2026. Creotech Instruments S.A. (WSE:CRI) completed the Spin-Off of Creotech Quantum S.A. on April 2, 2026. Final record date for entitlement to the distribution is April 2, 2026. Creotech Quantum debut on WSE scheduled for April 17, 2026.お知らせ • Aug 25Creotech Instruments S.A. to Report First Half, 2025 Results on Sep 26, 2025Creotech Instruments S.A. announced that they will report first half, 2025 results on Sep 26, 2025お知らせ • May 19Creotech Instruments S.A., Annual General Meeting, Jun 16, 2025Creotech Instruments S.A., Annual General Meeting, Jun 16, 2025.Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł8.33m (down 11% from 2Q 2023). Net loss: zł4.22m (loss widened 17% from 2Q 2023).New Risk • Sep 30New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €89.1m (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 92% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (€89.1m market cap, or US$99.2m).New Risk • Aug 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risks Share price has been volatile over the past 3 months (6.7% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).お知らせ • May 21Creotech Instruments S.A., Annual General Meeting, Jun 24, 2024Creotech Instruments S.A., Annual General Meeting, Jun 24, 2024.New Risk • Mar 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).New Risk • Feb 13New major risk - Revenue and earnings growthRevenue has declined by 8.5% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding).お知らせ • Feb 02+ 3 more updatesCreotech Instruments S.A. to Report First Half, 2024 Results on Sep 27, 2024Creotech Instruments S.A. announced that they will report first half, 2024 results on Sep 27, 2024New Risk • Dec 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 20% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).New Risk • Oct 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.2% average weekly change). Market cap is less than US$100m (€89.3m market cap, or US$94.8m).お知らせ • Jun 04Creotech Instruments S.A., Annual General Meeting, Jun 30, 2023Creotech Instruments S.A., Annual General Meeting, Jun 30, 2023, at 10:00 Central European Standard Time.お知らせ • Feb 03+ 2 more updatesCreotech Instruments S.A. to Report Q3, 2023 Results on Nov 27, 2023Creotech Instruments S.A. announced that they will report Q3, 2023 results on Nov 27, 2023Reported Earnings • Nov 27Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: zł4.91m (down 26% from 3Q 2021). Net loss: zł2.24m (down 451% from profit in 3Q 2021).Reported Earnings • Oct 04Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł2.59m (down 61% from 2Q 2021). Net loss: zł2.93m (down zł3.57m from profit in 2Q 2021).お知らせ • Jul 26Creotech Instruments S.A. to Report Q2, 2023 Results on Sep 28, 2022Creotech Instruments S.A. announced that they will report Q2, 2023 results on Sep 28, 2022お知らせ • Jun 07Creotech Instruments S.A., Annual General Meeting, Jun 30, 2022Creotech Instruments S.A., Annual General Meeting, Jun 30, 2022, at 14:00 Central European Standard Time.お知らせ • Jan 30+ 4 more updatesCreotech Instruments S.A. to Report Q1, 2022 Results on May 16, 2022Creotech Instruments S.A. announced that they will report Q1, 2022 results on May 16, 2022決済の安定と成長配当データの取得安定した配当: 5OBの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: 5OBの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Creotech Instruments 配当利回り対市場5OB 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (5OB)32.4%市場下位25% (DE)1.5%市場トップ25% (DE)4.7%業界平均 (Aerospace & Defense)1.0%アナリスト予想 (5OB) (最長3年)0%注目すべき配当: 5OBの配当金 ( 32.45% ) はGerman市場の配当金支払者の下位 25% ( 1.5% ) よりも高くなっています。高配当: 5OBの配当金 ( 32.45% ) はGerman市場 ( 4.72% ) の配当支払者の中で上位 25% に入っています。株主への利益配当収益カバレッジ: 5OBの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: 5OBが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YDE 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/17 14:27終値2026/07/14 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Creotech Instruments S.A. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jun 11Creotech Instruments S.A. has completed a Follow-on Equity Offering in the amount of €481 million.Creotech Instruments S.A. has completed a Follow-on Equity Offering in the amount of €481 million. Security Name: Series M Ordinary Bearer Shares Security Type: Common Stock Securities Offered: 650,000 Price\Range: €740 Transaction Features: Regulation S; Subsequent Direct Listing
Reported Earnings • Jun 04First quarter 2026 earnings released: zł2.95 loss per share (vs zł0.59 profit in 1Q 2025)First quarter 2026 results: zł2.95 loss per share (down from zł0.59 profit in 1Q 2025). Revenue: zł18.0m (down 30% from 1Q 2025). Net loss: zł8.41m (down zł9.82m from profit in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has increased by 64% per year, which means it is tracking significantly ahead of earnings growth.
New Risk • Jun 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding).
お知らせ • May 08Creotech Instruments S.A., Annual General Meeting, Jun 03, 2026Creotech Instruments S.A., Annual General Meeting, Jun 03, 2026, at 14:00 Central European Standard Time.
お知らせ • Apr 04Creotech Instruments S.A. (WSE:CRI) completed the Spin-Off of Creotech Quantum S.A.Creotech Instruments S.A. (WSE:CRI) agreed to Spin-Off Quantum segments on April 17, 2025. As part of the spinoff, Creotech Instruments shareholders will be allocated shares in the new quantum company in proportion to their holdings. The allocation of shares will take place through a public offering of shares. The quantum company is expected to go public on the WSE, at the same time, a new company will be created to focus on the development and commercialization of quantum systems so far developed at Creotech and assuming the prospectus procedure before Poland's financial market regulator KNF and the receival of all corporate approvals proceeds without delay and the spinoff proposal receives the approval of the shareholders. The estimated date for concluding the spinoff is late 2025/early 2026. Creotech Instruments S.A. (WSE:CRI) completed the Spin-Off of Creotech Quantum S.A. on April 2, 2026. Final record date for entitlement to the distribution is April 2, 2026. Creotech Quantum debut on WSE scheduled for April 17, 2026.
お知らせ • Aug 25Creotech Instruments S.A. to Report First Half, 2025 Results on Sep 26, 2025Creotech Instruments S.A. announced that they will report first half, 2025 results on Sep 26, 2025
お知らせ • May 19Creotech Instruments S.A., Annual General Meeting, Jun 16, 2025Creotech Instruments S.A., Annual General Meeting, Jun 16, 2025.
Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł8.33m (down 11% from 2Q 2023). Net loss: zł4.22m (loss widened 17% from 2Q 2023).
New Risk • Sep 30New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €89.1m (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 92% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (€89.1m market cap, or US$99.2m).
New Risk • Aug 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risks Share price has been volatile over the past 3 months (6.7% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).
お知らせ • May 21Creotech Instruments S.A., Annual General Meeting, Jun 24, 2024Creotech Instruments S.A., Annual General Meeting, Jun 24, 2024.
New Risk • Mar 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).
New Risk • Feb 13New major risk - Revenue and earnings growthRevenue has declined by 8.5% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding).
お知らせ • Feb 02+ 3 more updatesCreotech Instruments S.A. to Report First Half, 2024 Results on Sep 27, 2024Creotech Instruments S.A. announced that they will report first half, 2024 results on Sep 27, 2024
New Risk • Dec 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 20% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding).
New Risk • Oct 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.2% average weekly change). Market cap is less than US$100m (€89.3m market cap, or US$94.8m).
お知らせ • Jun 04Creotech Instruments S.A., Annual General Meeting, Jun 30, 2023Creotech Instruments S.A., Annual General Meeting, Jun 30, 2023, at 10:00 Central European Standard Time.
お知らせ • Feb 03+ 2 more updatesCreotech Instruments S.A. to Report Q3, 2023 Results on Nov 27, 2023Creotech Instruments S.A. announced that they will report Q3, 2023 results on Nov 27, 2023
Reported Earnings • Nov 27Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: zł4.91m (down 26% from 3Q 2021). Net loss: zł2.24m (down 451% from profit in 3Q 2021).
Reported Earnings • Oct 04Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł2.59m (down 61% from 2Q 2021). Net loss: zł2.93m (down zł3.57m from profit in 2Q 2021).
お知らせ • Jul 26Creotech Instruments S.A. to Report Q2, 2023 Results on Sep 28, 2022Creotech Instruments S.A. announced that they will report Q2, 2023 results on Sep 28, 2022
お知らせ • Jun 07Creotech Instruments S.A., Annual General Meeting, Jun 30, 2022Creotech Instruments S.A., Annual General Meeting, Jun 30, 2022, at 14:00 Central European Standard Time.
お知らせ • Jan 30+ 4 more updatesCreotech Instruments S.A. to Report Q1, 2022 Results on May 16, 2022Creotech Instruments S.A. announced that they will report Q1, 2022 results on May 16, 2022